AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇲
Efavirenz + Lamivudine + Tenofovir Disoproxil Fumarate in Zambia
1 product registered with ZAMRA — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Efavirenz 400mg + Lamivudine 300mg + Tenofovir Disoproxil Fumarate 300mg Tablets Film Coated Tablets | ZAMRA-HM-23-69 | Hetero Labs Limited | active | 31 Aug 2028 |
Efavirenz + Lamivudine + Tenofovir Disoproxil Fumarate — ZAMRA Registration Details
ZAMRA (Zambia) has 1 registered product containing Efavirenz + Lamivudine + Tenofovir Disoproxil Fumarate, of which 1 is currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track Efavirenz + Lamivudine + Tenofovir Disoproxil Fumarate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.